Page last updated: 2024-12-08
minimycin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
minimycin: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 161746 |
| CHEMBL ID | 3144030 |
| SCHEMBL ID | 6338652 |
| MeSH ID | M0042906 |
Synonyms (13)
| Synonym |
|---|
| 2h-1,3-oxazine-2,4(3h)-dione, 5-beta-d-ribofuranosyl- |
| 32388-21-9 |
| minimycin, oxazinomycin |
| 5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3-oxazine-2,4-dione |
| minimycin |
| 5-beta-d-ribofuranosyl-1,3-oxazine-2,4-dione |
| (1s)-1,4-anhydro-1-(2,4-dioxo-3,4-dihydro-2h-1,3-oxazin-5-yl)-d-ribitol |
| 5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-oxazine-2,4-dione |
| SCHEMBL6338652 |
| CHEMBL3144030 |
| DTXSID10186102 |
| 5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-1,3-oxazine-2,4-dione |
| d-ribitol, 1,4-anhydro-1-c-(3,4-dihydro-2,4-dioxo-2h-1,3-oxazin-5-yl)-, (1s)- |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (3)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID98206 | Antitumor activity against L1210 cells | 1981 | Journal of medicinal chemistry, Oct, Volume: 24, Issue:10 | Synthesis and biological activity of certain derivatives of oxazinomycin and related oxadiazole nucleosides. |
| AID86973 | Antitumor activity against HeLa cells | 1981 | Journal of medicinal chemistry, Oct, Volume: 24, Issue:10 | Synthesis and biological activity of certain derivatives of oxazinomycin and related oxadiazole nucleosides. |
| AID97745 | Inhibition against L1210 cells growth at 8*10e-7 M. | 1981 | Journal of medicinal chemistry, Oct, Volume: 24, Issue:10 | Synthesis and biological activity of certain derivatives of oxazinomycin and related oxadiazole nucleosides. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (11)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 96.55
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (96.55) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (18.18%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (81.82%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||